Fox, Elizabeth <br/><br/>
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Aug 2013 
 - 4239-48 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-13-0071  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Carcinoma, Medullary--drug therapy<br/>Carcinoma, Neuroendocrine<br/>Child<br/>Child, Preschool<br/>Drug-Related Side Effects and Adverse Reactions--pathology<br/>Gene Expression Regulation, Neoplastic<br/>Germ-Line Mutation<br/>Humans<br/>Multiple Endocrine Neoplasia Type 2b--drug therapy<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local--drug therapy<br/>Piperidines--administration & dosage<br/>Protein-Tyrosine Kinases--genetics<br/>Proto-Oncogene Mas<br/>Proto-Oncogene Proteins c-ret--genetics<br/>Quinazolines--administration & dosage<br/>Thyroid Neoplasms--drug therapy